Wegovy
GLP-1s May Be Blunting the Buzz & Changing How We Drink
A preliminary study shows GLP-1 drugs like Ozempic may slow alcohol absorption and reduce feelings of intoxication.
GLP-1s Opened the Door, Hims & Hers Says Personalization Holds the Key
Hims & Hers' Dr. Craig Primack explains why personalized care, not just GLP-1s, is the key to lasting weight loss success.
Wegovy Partnership Unravels as Novo Nordisk, Hims & Hers Trade Accusations
Novo Nordisk ends its Wegovy deal with Hims & Hers, citing safety concerns as the telehealth firm pushes back.
Found Adds Direct Access to Wegovy & Zepbound From $349
Found is now offering Wegovy and Zepbound through direct-to-consumer pharmacy programs, expanding access to GLP-1 medications.
WeightWatchers Files for Chapter 11, Vows its ‘Here to Stay’
WeightWatchers has filed for Chapter 11 bankruptcy as part of a financial restructuring and a renewed focus on telehealth.
Hims & Hers Joins Forces With Novo Nordisk
Hims & Hers and Novo Nordisk are teaming to expand affordable access to weight loss treatments, launching a bundled Wegovy offering.
The Foods Capturing the Wallet Share of GLP-1 Users
Weight-reducing drugs such as Ozempic and Wegovy are changing how Americans eat, paving the way for nutrition brands to make their mark.
Equinox Designs Training Program for Members on Weight Loss Drugs
Luxury fitness brand Equinox is creating a program designed to help Ozempic and Wegovy users build long-term, healthy habits.
Hims Enters Weight Loss Market, but CEO Not Sold on Ozempic
Hims' new platform will roll out just in time for New Year’s resolutions, but will lean on generic medications instead of highly popular GLP-1s.
Wegovy Maker Sues Wellness Clinics, Spas Over Counterfeit Weight-Loss Drugs
Novo Nordisk has filed lawsuits against wellness clinics and spas for selling non-FDA-approved versions of its weight-loss drugs.
